期刊文献+

我院2004~2006年住院部抗过敏药利用分析 被引量:6

Use of Antiallergic Drugs in Inpatient Pharmacy of Our Hospital During 2004~2006
原文传递
导出
摘要 目的:评价我院住院部抗过敏药的利用现状。方法:对我院2004~2006年住院部非手术科室、手术科室和儿科抗过敏药的品种、销售金额、用药频度(DDDs)等进行统计、分析。结果:抗过敏药销售金额及DDDs呈现波动,2006年有所下降,用药结构变化不大。结论:不断有抗过敏新药上市,但应用仍以价格较低廉的品种为主。 OBJECTIVE: To evaluate the status quo of the use of antiallergic drugs.METHODS: The antiallergic drugs used during 2004-2006 in the inpatient pharmacy including the non- surgery department, surgery department and pediatric department of our hospital were analyzed statistically in respect of kinds, consumption sum and DDDs.RESULTS: The antiallergic drugs had a fluctuation in consumption sum and DDDs,showing a reduction in 2006. No significant change was noted in the structure of drug use.CONCLUSION: More and more new antiallergic drugs went on the market, but the application still gives priority to the cheaper kinds.
出处 《中国药房》 CAS CSCD 北大核心 2007年第17期1304-1306,共3页 China Pharmacy
关键词 抗过敏药 用药频度 分析 Antiallergic drugs DDDs Analysis
  • 相关文献

参考文献2

二级参考文献21

  • 1Anthes JC, Richard C, West RE, et al. Functional characterization of desloratadine and other antihistamines in a Chinese Hamster Ovary (CHO) cell line that expresses the cloned human bronchial smooth muscle cells ( HBSMC ). J Allergy Clin Immunol, 2000,104 (1Pt2):S385.
  • 2Kreutner W, Hey JA, Anthes J, et al. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine HI receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittelforschung, 2000, 50(4) :345-352.
  • 3Cardelus I, Anton F, Beleta J, et al. Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle. Eur J Pharmacol, 1999, 374(2) :249-254.
  • 4Bayram H, Devalia JL, Khair OA,et al. Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J Allergy Clin Immunol, 1999, 104(1) :93-99.
  • 5Kleine-Tebbe J, Josties C, Frank G, et al. Inhibition of IgE- and nonIgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine. J Allergy Clin Immunol, 1994, 93(2) :494-500.
  • 6Kreutner W, Hey JA, Chiu P, et al. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects. Arzneimittelforschung, 2000, 50 (5) :441-448.
  • 7Banfield C, Padhi D, Glue P, et al. Electrocardiographic effects of multiple high doses of desloratadine. J Allergy Clin Immunol, 2000,104(1 Pt2) :S383.
  • 8Hey J, Anthes J, Barnett A, et al. Preclinical cardiovascular and CNS safety profile of desloratadine, a selective and nonsedating histamine H1-receptor antagonist. J Allergy Clin Immunol,2000,104(1Pt2):S383.
  • 9Vuurman E, Ramaekers JG, Rikken G, et al. Desloratadine does not impair actual driving performance: a 3-way crossover comparison with diphenhydramin and placbo . Allergy, 2000,55 ( Suppl 63 ): 263 -264.
  • 10Herron JM,Padhi D,Affrime MB, et al. Dose-proportionality, linearity, and pharmackinetics of desloratadine in health y adults. J Allergy Clin Immunol, 2000,104 (1 Pt 2) :S385.

共引文献15

同被引文献30

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部